Saint Luke's Mid America Heart Institute

Saint Luke's Mid America Heart Institute


Saint Luke’s Mid America Heart Institute offers the most comprehensive heart and vascular care in Kansas City. We provide the full range of cardiovascular services, from disease prevention to heart transplantation. At Saint Luke’s we use the latest technology to provide a full range of services and treatments. 

We provide:

  • More specialized physicians
  • More experience
  • More innovative treatment options for patients

Saint Luke’s Hospital is proud to be ranked 42 in the nation for cardiology and heart surgery by U.S. News & World Report and is the third hospital in the U.S to achieve Comprehensive Cardiac Center certification from The Joint Commission.

Services

Research and Clinical Trials

Cardiovascular research continues to be a major focus at Saint Luke’s Health System. The program currently encompasses research programs in each of the major clinical areas, including interventional cardiology, cardiac surgery, heart failure and cardiac transplantation, cardiac electrophysiology, cardiac imaging, and preventive cardiology/lipid and diabetes management.

In addition to supporting clinical research, the cardiovascular research program encompasses centers of excellence and core laboratories in:

  • Cardiovascular outcomes research
  • Health economics and technology assessment
  • Intravascular imaging
  • Noninvasive imaging

These centers of excellence currently serve as core laboratories for a wide range of studies that often involve collaboration with other leading cardiovascular centers and researchers from around the world. MAHI continues to serve as one of the four Analytic Centers, along with Duke, Harvard, and Yale, for the American College of Cardiology’s National Cardiovascular Data Registry.

0.0 miles away

Saint Luke's Mid America Heart Institute

4401 Wornall Rd
Kansas City, MO 64111 

Phone: 816-931-1883

Saint Luke's News

TCTMD: ISCHEMIA in Print: New MI Data and More Calls for Longer Follow-up
The ISCHEMIA (International Study of Comparative Health Effectiveness with Medical and Invasive Approaches) trial focused on evaluating survival and benefits to the patients quality of life.
NIH-funded studies show stents and surgery no better than medication, lifestyle changes at reducing cardiac events
Saint Luke's Director of Health Outcomes and Research at Saint Luke's Mid America Heart Institute helps in NIH-funded studies that find stents, surgery provide higher quality of life for those with chest pain.
Cardiovascular Business: Pop Goes the Pillbox: Will Polypharmacy Problems Limit the Adoption of SGLT2 Inhibitors?
Cardiovascular Business talked to Mikhail Kosiborod, MD, to find out if polypharmacy problems could limit the adoption of SGLT2 inhibitors--the new promising treatment for heart failure and type 2 diabetes.